EPISODE · May 4, 2026 · 1 MIN
Ocular Therapeutix Earnings: Turnaround Moment?
from The Daily News Now! Business
Ocular Therapeutix, OCUL, releases earnings Tuesday, aiming to reverse a sales slump. Analysts predict a 20.8% Y/Y revenue surge, but the company has a history of missing targets. Peers like Eli Lilly and Merck outperformed, driving share gains. OCUL surged 16.5% last month, with a $26 price target looming. A turnaround could boost this hot sectors stock. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/921c39ff9d746ae6
NOW PLAYING
Ocular Therapeutix Earnings: Turnaround Moment?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m